Cardiology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden School of Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Cardiology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
Heart. 2014 Aug;100(16):1235-41. doi: 10.1136/heartjnl-2014-305599. Epub 2014 Apr 17.
This study aimed to describe the contemporary aetiology, clinical characteristics and mortality and its predictors in heart failure (HF) in Tanzania.
Design; Prospective observational study. Setting; Cardiovascular Center of the Muhimbili National Hospital in Dar es Salaam, Tanzania. Patients ≥18 years of age with HF defined by the Framingham criteria.
All-cause mortality.
Among 427 included patients, 217 (51%) were females and the mean (SD) age was 55 (17) years. HF aetiologies included hypertension (45%), cardiomyopathy (28%), rheumatic heart disease (RHD) (12%) and ischaemic heart disease (9%). Concurrent atrial fibrillation (AF), clinically significant anaemia, diabetes, tuberculosis and HIV were found in 16%, 12%, 12%, 3% and 2%, respectively, while warfarin was used in 3% of the patients. The mortality rate, 22.4 per 100 person-years over a median follow-up of 7 months, was independently associated with AF, HR 3.4 (95% CI 1.6 to 7.0); in-patient 3.2 (1.5 to 6.8); anaemia 2.3 (1.2 to 4.5); pulmonary hypertension 2.1 (1.1 to 4.2) creatinine clearance 0.98 (0.97 to 1.00) and lack of education 2.3 (1.3 to 4.2).
In HF in Tanzania, patients are younger than in the developed world, but aetiologies are becoming more similar, with hypertension becoming more and RHD less important. Predictors of mortality possible to intervene against are anaemia, AF and lack of education.
本研究旨在描述坦桑尼亚心力衰竭(HF)的当代病因、临床特征和死亡率及其预测因素。
设计;前瞻性观察性研究。地点;坦桑尼亚达累斯萨拉姆穆希比利国家医院心血管中心。年龄≥18 岁,HF 按 Framingham 标准定义。
全因死亡率。
在纳入的 427 名患者中,217 名(51%)为女性,平均(SD)年龄为 55(17)岁。HF 的病因包括高血压(45%)、心肌病(28%)、风湿性心脏病(RHD)(12%)和缺血性心脏病(9%)。同时存在心房颤动(AF)、临床显著贫血、糖尿病、结核病和 HIV 的患者分别为 16%、12%、12%、3%和 2%,而华法林的使用率为 3%。中位随访 7 个月期间,死亡率为 22.4/100 人年,与 AF(HR 3.4[95%CI 1.6 至 7.0])、住院(3.2[1.5 至 6.8])、贫血(2.3[1.2 至 4.5])、肺动脉高压(2.1[1.1 至 4.2])、肌酐清除率 0.98(0.97 至 1.00)和缺乏教育(2.3[1.3 至 4.2])独立相关。
在坦桑尼亚的 HF 中,患者比发达国家的患者年轻,但病因变得更加相似,高血压变得越来越重要,而 RHD 变得不那么重要。可能干预的死亡率预测因素包括贫血、AF 和缺乏教育。